These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32621027)

  • 21. Comparison between "In-bore" MRI guided prostate biopsy and standard ultrasound guided biopsy in the patient with suspicious prostate cancer: Preliminary results.
    D'Agostino D; Mineo Bianchi F; Romagnoli D; Corsi P; Giampaoli M; Schiavina R; Brunocilla E; Artibani W; Porreca A
    Arch Ital Urol Androl; 2019 Jul; 91(2):. PubMed ID: 31266272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In-bore MRI-guided prostate biopsy in a patient group with PI-RADS 4 and 5 targets: A single center experience.
    Vural M; Coskun B; Kilic M; Durmaz S; Gumus T; Cengiz D; Onay A; Saglican Y; Colakoglu B; Akpek S; Yildirim H; Esen T; Rozanes I
    Eur J Radiol; 2021 Aug; 141():109785. PubMed ID: 34091134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiparametric MRI-ultrasonography software fusion prostate biopsy: initial results using a stereotactic robotic-assisted transperineal prostate biopsy platform comparing systematic vs targeted biopsy.
    Lee AYM; Yang XY; Lee HJ; Law YM; Huang HH; Lau WKO; Lee LS; Ho HSS; Tay KJ; Cheng CWS; Yuen JSP; Chen K
    BJU Int; 2020 Nov; 126(5):568-576. PubMed ID: 32438463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T1 Mapping of the Prostate Using Single-Shot T1FLASH: A Clinical Feasibility Study to Optimize Prostate Cancer Assessment.
    Al-Bourini O; Seif Amir Hosseini A; Giganti F; Balz J; Heitz LG; Voit D; Lotz J; Trojan L; Frahm J; Uhlig A; Uhlig J
    Invest Radiol; 2023 Jun; 58(6):380-387. PubMed ID: 36729865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate cancer detection on transrectal ultrasonography-guided random biopsy despite negative real-time magnetic resonance imaging/ultrasonography fusion-guided targeted biopsy: reasons for targeted biopsy failure.
    Cash H; Günzel K; Maxeiner A; Stephan C; Fischer T; Durmus T; Miller K; Asbach P; Haas M; Kempkensteffen C
    BJU Int; 2016 Jul; 118(1):35-43. PubMed ID: 26384851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accuracy of cognitive MRI-targeted biopsy in hitting prostate cancer-positive regions of interest.
    Cerantola Y; Haberer E; Torres J; Alameldin M; Aronson S; Levental M; Bladou F; Anidjar M
    World J Urol; 2016 Jan; 34(1):75-82. PubMed ID: 25981403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparing Three Different Techniques for Magnetic Resonance Imaging-targeted Prostate Biopsies: A Systematic Review of In-bore versus Magnetic Resonance Imaging-transrectal Ultrasound fusion versus Cognitive Registration. Is There a Preferred Technique?
    Wegelin O; van Melick HHE; Hooft L; Bosch JLHR; Reitsma HB; Barentsz JO; Somford DM
    Eur Urol; 2017 Apr; 71(4):517-531. PubMed ID: 27568655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Critical Analysis of the Magnetic Resonance Imaging Lesion Diameter Threshold for Adverse Pathology Features.
    Danacioglu YO; Turkay R; Yildiz O; Polat S; Arikan Y; Polat H; Yenice MG; Baytekin HF; Inci E; Tasci Aİ
    Prague Med Rep; 2023; 124(1):40-51. PubMed ID: 36763830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of free-hand transperineal targeted prostate biopsy using multiparametric magnetic resonance imaging-transrectal ultrasound fusion in Chinese men with prior negative biopsy and elevated prostate-specific antigen.
    Lian H; Zhuang J; Wang W; Zhang B; Shi J; Li D; Fu Y; Jiang X; Zhou W; Guo H
    BMC Urol; 2017 Jul; 17(1):52. PubMed ID: 28679370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gleason Grade Group Concordance between Preoperative Targeted Biopsy and Radical Prostatectomy Histopathologic Analysis: A Comparison Between In-Bore MRI-guided and MRI-Transrectal US Fusion Prostate Biopsies.
    Costa DN; Cai Q; Xi Y; Recchimuzzi DZ; Subramanian N; Bagrodia A; Rofsky NM; Roehrborn CG; Hornberger B; Shah RB; Goldberg K; Diaz de Leon A; Pedrosa I
    Radiol Imaging Cancer; 2021 Mar; 3(2):e200123. PubMed ID: 33817652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suboptimal Prediction of Clinically Significant Prostate Cancer in Radical Prostatectomy Specimens by mpMRI-Targeted Biopsy.
    Karsiyakali N; Ozgen MB; Ozveren B; Akbal C; Dincer A; Durak H; Turkeri L
    Urology; 2021 Feb; 148():217-223. PubMed ID: 32871139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy.
    Gandaglia G; Ploussard G; Valerio M; Mattei A; Fiori C; Roumiguié M; Fossati N; Stabile A; Beauval JB; Malavaud B; Scuderi S; Barletta F; Moschini M; Zamboni S; Rakauskas A; Tian Z; Karakiewicz PI; De Cobelli F; Porpiglia F; Montorsi F; Briganti A
    Eur Urol; 2020 Jun; 77(6):733-741. PubMed ID: 31547938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Magnetic resonance imaging in prostate cancer detection and management: a systematic review.
    Monni F; Fontanella P; Grasso A; Wiklund P; Ou YC; Randazzo M; Rocco B; Montanari E; Bianchi G
    Minerva Urol Nefrol; 2017 Dec; 69(6):567-578. PubMed ID: 28488844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lesion location agreement between prostatic multiparametric magnetic resonance, cognitive fusion biopsy and radical prostatectomy piece.
    Lourenço M; Pissarra P; E Brito DV; Eliseu M; Peralta JP; Figueiredo A; Marques C
    Arch Ital Urol Androl; 2020 Jan; 91(4):218-223. PubMed ID: 31937086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In-Bore Versus Fusion MRI-Targeted Biopsy of PI-RADS Category 4 and 5 Lesions: A Retrospective Comparative Analysis Using Propensity Score Weighting.
    Prince M; Foster BR; Kaempf A; Liu JJ; Amling CL; Isharwal S; Chen Y; Coakley FV
    AJR Am J Roentgenol; 2021 Nov; 217(5):1123-1130. PubMed ID: 33646819
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of multiparametric resonance and biopsy in prostate cancer detection: comparison with definitive histological report after laparoscopic/robotic radical prostatectomy.
    Rapisarda S; Bada M; Crocetto F; Barone B; Arcaniolo D; Polara A; Imbimbo C; Grosso G
    Abdom Radiol (NY); 2020 Dec; 45(12):4178-4184. PubMed ID: 33048224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A negative multiparametric magnetic resonance imaging finding does not guarantee the absence of significant cancer among biopsy-proven prostate cancer patients: a real-life clinical experience.
    Kim JJ; Byun SS; Lee SE; Lee HJ; Choe G; Hong SK
    Int Urol Nephrol; 2018 Nov; 50(11):1989-1997. PubMed ID: 30229465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of clinically significant prostate cancer in biopsy-naïve men: direct comparison of systematic biopsy, multiparametric MRI- and contrast-ultrasound-dispersion imaging-targeted biopsy.
    Mannaerts CK; Engelbrecht MRW; Postema AW; van Kollenburg RAA; Hoeks CMA; Savci-Heijink CD; Van Sloun RJG; Wildeboer RR; De Reijke TM; Mischi M; Wijkstra H
    BJU Int; 2020 Oct; 126(4):481-493. PubMed ID: 32315112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk-based Patient Selection for Magnetic Resonance Imaging-targeted Prostate Biopsy after Negative Transrectal Ultrasound-guided Random Biopsy Avoids Unnecessary Magnetic Resonance Imaging Scans.
    Alberts AR; Schoots IG; Bokhorst LP; van Leenders GJ; Bangma CH; Roobol MJ
    Eur Urol; 2016 Jun; 69(6):1129-34. PubMed ID: 26651990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.